[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Ramiro Peru Biography and Net Worth

Director of Elevance Health

Ramiro G. Peru is a Independent Director of Anthem, Inc. He has been a director of the Company since November 2004. Mr. Peru served on the former WHN board of directors from May 2003 until WHN’s merger with us in November 2004. During the second half of 2007, Mr. Peru was Executive Vice President and Chief Financial Officer of Swift Corporation (transportation) and prior thereto was Executive Vice President and Chief Financial Officer of Phelps Dodge Corporation (mining and manufacturing) from 1999 to 2007 (“Phelps Dodge”). Mr. Peru joined Phelps Dodge in 1979 and held various finance and accounting positions with Phelps Dodge and its affiliates. Mr. Peru has served as a director of SM Energy Company (oil and gas exploration and production company) since 2014, UNS Energy Corporation (electric and gas utility holding company) since 2007 and Bluemedia, Inc. (large format printer) since 2018.

What is Ramiro G. Peru's net worth?: The estimated net worth of Ramiro G. Peru is at least $3.52 million as of August 5th, 2024. Mr. Peru owns 8,744 shares of Elevance Health stock worth more than $3,519,897 as of November 22nd. This net worth approximation does not reflect any other investments that Mr. Peru may own. Learn More about Ramiro G. Peru's net worth.
How do I contact Ramiro G. Peru?: The corporate mailing address for Mr. Peru and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Ramiro G. Peru's contact information.
Has Ramiro G. Peru been buying or selling shares of Elevance Health?: Ramiro G. Peru has not been actively trading shares of Elevance Health during the last quarter. Most recently, Ramiro G. Peru sold 753 shares of the business's stock in a transaction on Monday, August 5th. The shares were sold at an average price of $531.52, for a transaction totalling $400,234.56. Following the completion of the sale, the director now directly owns 8,744 shares of the company's stock, valued at $4,647,610.88. Learn More on Ramiro G. Peru's trading history.
Who are Elevance Health's active insiders?: Elevance Health's insider roster includes Gail Boudreaux (President, CEO & Director), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.
Are insiders buying or selling shares of Elevance Health?: In the last year, insiders at the sold shares 6 times. They sold a total of 57,339 shares worth more than $28,701,403.88. The most recent insider tranaction occured on October, 18th when EVP Charles Morgan Kendrick Jr sold 7,417 shares worth more than $3,205,182.38. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.
Information on this page was last updated on 10/18/2024.

Ramiro G. Peru Insider Trading History at Elevance Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/5/2024	Sell	753	$531.52	$400,234.56	8,744
2/7/2024	Sell	753	$500.00	$376,500.00	9,109
5/19/2022	Sell	990	$468.88	$464,191.20	9,405
5/24/2021	Sell	1,308	$398.02	$520,610.16	9,462
5/21/2019	Sell	1,656	$275.00	$455,400.00	11,173
5/30/2017	Sell	2,681	$181.58	$486,815.98	13,571
6/29/2016	Sell	3,125	$130.00	$406,250.00	15,262
6/1/2015	Sell	4,709	$167.91	$790,688.19

Ramiro G. Peru Buying and Selling Activity at Elevance Health

Elevance Health Company Overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Today's Range

Now: $402.55

$400.34

$406.73

50 Day Range

MA: $460.70

$394.20

$553.50

2 Week Range

Now: $402.55

$391.02

$567.26

Volume

1,178,869 shs

Average Volume

1,176,305 shs

Market Capitalization

$93.36 billion

P/E Ratio

14.68

Dividend Yield

1.65%

Beta

0.85